Nonalcoholic steatohepatitis: An evolving diagnosis

Canadian Journal of Gastroenterology

Volumn 14, Issue 4, 2000, Pages 321-326

  Neuschwander Tetri, Brent A ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Liver transplantation; Nonalcoholic steatohepatitis; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; FATIGUE; FATTY LIVER; HEPATOMEGALY; HUMAN; HYPERINSULINISM; IMAGING; INFLAMMATORY INFILTRATE; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER TRANSPLANTATION; METABOLIC DISORDER; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; VIRUS INFECTION; WEIGHT REDUCTION;

EID: 0034022295     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/912735     Document Type: Review

References (26)

1. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-9.
2. Galamhos JT, Wills CE. Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology 1978;74:1191-5.
3. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995;127:700-4.
4. Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastro 1987;82:650-4.
5. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594-8.
6. Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis. Mayo Clin Proc 1980;55:434-8.
7. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-10.
8. Ikai E, Ishizaki M, Suzuki Y, Ishida M, Noborizaka Y, Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people. J Hum Hyperten 1995;9:101-5.
9. Batman PA, Scheuer PJ. Diabetic hepatitis preceding the onset of glucose intolerance. Histopathology 1985;9:237-43.
10. Powell EE, Cooksley WG, Hanson R, Searle J, Hailiday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
11. Powell EE, Searle J, Mortimer R. Steatohepatitis associated with limb lipodystrophy. Gastroenterology 1989;97:1022-4.
12. el-Hassan AY, Ibrahim EM, al-Mulhim FA, Nabhan AA, Chammas MY. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 1992;65:774-8.
13. Fromenty B, Berson A, Pessayre D. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 1997;26(Suppl 1):13-22.
14. Gruffat D, Durand D, Graulet B, Bauchart D. Regulation of VLDL synthesis and secretion in the liver. Reprod Nutr Dev 1996;36:375-89.
15. Capron JP, Delamarre J, Dupas JL, et al. Fasting in obesity: another cause of liver injury with alcoholic hyaline? Dig Dis Sci 1982;27:265-8.
16. Rozental P, Biava C, Spencer H, et al. Liver morphology and function tests in obesity and during starvation. Am J Dig Dis 1967;12:198-208.
17. Cotrim HP, Freitas LA, Parana R, et al. Non-alcoholic steatohepatitis (NASH) and environmental toxins: A liver disease in workers from an industrial area. Hepatology 1986;24:337.
18. Yeh SH, Wu LC, Wang SJ, et al. Xenon-133 hepatic retention ratio: a useful index for fatty liver quantification. J Nucl Med 1989;30:1708-12.
19. Lee RG. Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. Hepatology 1995;21:1742-3.
20. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994;125:239-41.
21. Drenick EJ, Simmons F, Murphy JF. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small bowel bypass. N Engl J Med 1970;282:829-34.
22. Fiatarone JR, Coverdale SA, Batey RG, Farrell GC. Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. J Gastroenterol Hepatol 1991;6:585-90.
23. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis 1986;8:283-98.
24. Seeff LB, Zimmerman HI. Relationship between hepatic and pancreatic disease. In: Popper H, Schaffner F, eds. Progress in Liver Diseases, vol 5. New York: Grune and Stratton, 1976:590.
25. Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996;23:1464-7.
26. Lavine JE. Treatment of obesity-induced steatohepatitis with vitamin E. Gastroenterology 1998;114:A1284-5. (Abst)